On the contrary, tumor-infiltrating HBV-specific CD4+ T cells were significantly elevated compared with all control groups (non-HBV HCC, CHB, and HC) [40,53,68,71], with Tregs being the predominant CD4+ T-cell subset [25,71]. The gene discussed is CD4; the disease is hepatocellular carcinoma.